Dr. Goodman is a physician-scientist. He is a hematologist, medical oncologist and clinical researcher at Comprehensive Cancer Centers of Nevada (CCCN). He participates in various basic, translational and clinical research studies at the practice. His translational research projects center around understanding mechanisms that govern cancer’s resistance to hormonal therapy, focusing on prostate cancer.
Dr. Goodman conducts translational research at Roseman University of Health Sciences, with colleagues on the Prostate Cancer Research team, part of the university’s Cancer Research Program. He serves as an Associate Professor of Internal Medicine at Roseman University College of Medicine.
Prior to joining CCCN in 2012, Dr. Goodman worked as a medical oncologist at the UC San Diego Nevada Cancer Institute. Before moving to Las Vegas, Dr. Goodman worked as a Clinical Associate and later as a physician for the Department of Medicine, Division of Hematology/Oncology, at New York Presbyterian Hospital, Weill Cornell Campus, in New York City.
He has earned multiple awards during his career. Dr. Goodman is a recipient of the Young Investigator Award from the American Society of Clinical Oncology and also has been named a Regional Top Doctor by US News and World Report and Castle-Connolly annually since 2008. He has been honored with the title of Research Healthcare Headliner by Vegas Inc. and received the 2014 Southern Nevada Technology & Research Healthcare Hero award by Nevada Business Magazine. He was awarded the Inspired Excellence in Health Care Award by Las Vegas HEALS. He is consistently recognized as a Top Doctor by Vegas Inc. and Desert Companion in its annual polls.
He has authored numerous abstracts, book chapters, and more than 40 peer-reviewed publications. He has received peer-reviewed translational research support through the Department of Defense.